Partial or radical nephrectomy for complex renal mass: a comparative analysis of oncological outcomes and complications from the ROSULA (Robotic Surgery for Large Renal Mass) Collaborative Group

Cerrato, Clara; Patel, Devin; Autorino, Riccardo; Simone, Giuseppe; Yang, Bo; Uzzo, Robert G.; Porpiglia, Francesco; Capitanio, Umberto; Porter, James; Beksaç, Alp Tuna; Minervini, Andrea; Antonelli, Alessandro; Cerruto, Maria Angela; Lau, Clayton; Ashrafi, Akbar; Eun, Daniel; Mottrie, Alexandre; Mir, Carmen; Meagher, Margaret; Puri, Dhruv; Nguyen, Minh-Khai; Dhanji, Sohail; Liu, Franklin; Pandolfo, Savio Domenico; Kutikov, Alexander; Montorsi, Francesco; Gill, Inderbir S.; Sundaram, Chandru P.; Kaouk, Jihad; Derweesh, Ithaar

doi:10.1007/s00345-023-04279-1

Cited by 21 publications

(14 citation statements)

References 44 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Lastly, EAU guidelines also report, among risk factors for more aggressive cancer, patients’ related characteristics, such as ethnicity, with African-American patients having worse outcomes, advancing age, tobacco consumption, delayed surgery, high comorbidity and performance indices scores, and several blood-based biomarkers even if no prognostic biomarkers are validated for clinical use (LE: 3) [ 43 , 44 , 45 , 46 , 47 ]. These latter characteristics are mentioned in the AUA/SUO, but the panel considers them to be not widely available, easily identified, or measured, thereby limiting broad applicability.…”

Section: Resultsmentioning

confidence: 99%

Upper Tract Urothelial Cancer: Guideline of Guidelines

Pandolfo,

Cilio,

Aveta

et al. 2024

Cancers

Self Cite

View full text Add to dashboard Cite

Background: Upper tract urothelial carcinoma (UTUC) is a rare disease with a potentially dismal prognosis. We systematically compared international guidelines on UTUC to analyze similitudes and differences among them. Methods: We conducted a search on MEDLINE/PubMed for guidelines related to UTUC from 2010 to the present. In addition, we manually explored the websites of urological and oncological societies and journals to identify pertinent guidelines. We also assessed recommendations from the International Bladder Cancer Network, the Canadian Urological Association, the European Society for Medical Oncology, and the International Consultation on Bladder Cancer, considering their expertise and experience in the field. Results: Among all the sources, only the American Urologist Association (AUA), European Association of Urology (EAU), and the National Comprehensive Cancer Network (NCCN) guidelines specifically report data on diagnosis, treatment, and follow-up of UTUC. Current analysis reveals several differences between all three sources on diagnostic work-up, patient management, and follow-up. Among all, AUA and EAU guidelines show more detailed indications. Conclusions: Despite the growing incidence of UTUC, only AUA, EAU, and NCCN guidelines deal with this cancer. Our research depicted high variability in reporting recommendations and opinions. In this regard, we encourage further higher-quality research to gain evidence creating higher grade consensus between guidelines.

show abstract

Section: Resultsmentioning

confidence: 99%

Upper Tract Urothelial Cancer: Guideline of Guidelines

Pandolfo,

Cilio,

Aveta

et al. 2024

Cancers

Self Cite

View full text Add to dashboard Cite

show abstract

“…R.E.N.A.L. score was used to evaluate tumor complexity, and scores were categorized into low (4-6), intermediate (7)(8)(9), and high (10-12) complexity as initially described by Kutikov and Uzzo. 18 Practice factors included annual PN volume (<20 or 20 cases) and practice type (academic, hybrid, or community) which were consistently defined in previous MUSIC analyses.…”

Section: Discussionmentioning

confidence: 99%

“…[5][6][7] Utilization of RPN has expanded to include larger and more complex tumors in many centers. [8][9][10] For every patient undergoing PN, there are risks, including the potential for conversion to RN.…”

mentioning

confidence: 99%

Conversion to Radical Nephrectomy From Robotic Partial Nephrectomy Is Most Commonly Due to Anatomic and Oncologic Complexity

Wang,

Wilder,

Butaney

et al. 2024

Journal of Urology

View full text Add to dashboard Cite

“…According to renal function, oncological, and quality of life (QoL) outcomes, localized T1 RCCs are best managed with partial nephrectomy (PN) rather than radical nephrectomy (RN), irrespective of the surgical approach ( 2 ). PN has become the reference standard for most T1 and an option in T2 renal cortical masses and RCC ( 2 – 4 ) and T3a tumors with oncological equipoise to RN and functional beneft in select patients ( 5 ). In the past, LPN had a steep learning curve, which restricted its use by urologists ( 6 ).…”

Section: Introductionmentioning

confidence: 99%

Clinical application of superselective transarterial embolization of renal tumors in zero ischaemia robotic-assisted laparoscopic partial nephrectomy

Li,

Hu,

et al. 2023

Front. Oncol.

View full text Add to dashboard Cite

ObjectiveTo assess the feasibility and safety of zero ischaemia robotic-assisted laparoscopic partial nephrectomy (RALPN) after preoperative superselective transarterial embolization (STE) of T1 renal cancer.MethodsWe retrospectively analyzed the data of 32 patients who underwent zero ischaemia RALPN after STE and 140 patients who received standard robot-assisted laparoscopic partial nephrectomy (S-RALPN). In addition, we selected 35 patients treated with off-clamp RALPN (O-RALPN) from September 2017 to March 2022 for comparison. STE was performed by the same interventional practitioner, and zero ischaemia laparoscopic partial nephrectomy (LPN) was carried out by experienced surgeon 1-12 hours after STE. The intraoperative data and postoperative complications were recorded. The postoperative renal function, routine urine test, urinary Computed Tomography (CT), and preoperative and postoperative glomerular filtration rate (GFR) data were analyzed.ResultsAll operations were completed successfully. There were no cases of conversion to opening and no deaths. The renal arterial trunk was not blocked. No blood transfusions were needed. The mean operation time was 91.5 ± 34.28 minutes. The mean blood loss was 58.59 ± 54.11 ml. No recurrence or metastasis occurred.ConclusionFor patients with renal tumors, STE of renal tumors in zero ischaemia RALPN can preserve more renal function, and it provides a safe and feasible surgical method.

show abstract

Partial or radical nephrectomy for complex renal mass: a comparative analysis of oncological outcomes and complications from the ROSULA (Robotic Surgery for Large Renal Mass) Collaborative Group

Cited by 21 publications

References 44 publications

Upper Tract Urothelial Cancer: Guideline of Guidelines

Upper Tract Urothelial Cancer: Guideline of Guidelines

Conversion to Radical Nephrectomy From Robotic Partial Nephrectomy Is Most Commonly Due to Anatomic and Oncologic Complexity

Clinical application of superselective transarterial embolization of renal tumors in zero ischaemia robotic-assisted laparoscopic partial nephrectomy

Contact Info

Product

Resources

About